title: Antiplatelet therapy may be continued after intracerebral hemorrhage.
authors.affiliation: From the Stroke Research Group, Division of Clinical Neurosciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom. Rustam.Al-Shahi@ed.ac.uk.
authors.forename: Rustam
authors.initials: R
authors.lastname: Al-Shahi Salman
authors.affiliation: From the Stroke Research Group, Division of Clinical Neurosciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.
authors.forename: Martin S
authors.initials: MS
authors.lastname: Dennis
mesh_terms: D000369:Aged, 80 and over; D001241:Aspirin / Q000627:therapeutic use*; D002543:Cerebral Hemorrhage / Q000453:epidemiology / Q000473:pathology*; D003072:Cognition Disorders / Q000453:epidemiology; D015897:Comorbidity; D005260:Female; D006801:Humans; D002546:Ischemic Attack, Transient / Q000188:drug therapy / Q000453:epidemiology; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*
chemical_list: D010975:Platelet Aggregation Inhibitors; D001241:Aspirin
keywords: aspirin; cerebral hemorrhage; magnetic resonance imaging; platelet aggregation inhibitors